Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tandem Diabetes Care
(NQ:
TNDM
)
32.51
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tandem Diabetes Care
< Previous
1
2
3
4
5
6
7
Next >
Tandem Diabetes Reports Mixed Q4 Earnings, Issues Better Than Expected FY22 Outlook
February 23, 2022
Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q4 sales reached $209.9 million, +25% Y/Y, beating the consensus of $199.12 million. The Company posted EPS of $0.16,...
Via
Benzinga
Expert Ratings For Tandem Diabetes Care
February 23, 2022
Over the past 3 months, 4 analysts have published their opinion on Tandem Diabetes Care (NASDAQ:TNDM) stock. These analysts are typically employed by large Wall Street banks and...
Via
Benzinga
Tandem Diabetes Care: Q4 Earnings Insights
February 22, 2022
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Stock Market Rallies After Fed Meeting, But Not For Long; Adobe, Rivian, Eli Lilly In Focus: Weekly Review
December 17, 2021
Adobe and Rivian fell on guidance, while Eli Lilly jumped on its raised targets.
Via
Investor's Business Daily
46 Biggest Movers From Yesterday
December 16, 2021
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 15, 2021
Gainers Biofrontera (NASDAQ:
Via
Benzinga
Analyzing Tandem Diabetes Care's Unusual Options Activity
August 05, 2021
On Thursday, shares of Tandem Diabetes Care (NASDAQ:TNDM)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...
Via
Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...
Via
Benzinga
Medtronic Hits FDA Snag For Diabetes Business — Leading A Rival To Pop
December 15, 2021
The FDA sent Medtronic a warning letter regarding its diabetes business.
Via
Investor's Business Daily
2 Unstoppable Growth Stocks That Could Double Your Money in 5 Years (or Less)
November 20, 2021
These companies have a history of crushing the market.
Via
The Motley Fool
Jim Cramer Shares His Thoughts On Innovative Industrial Properties, Nokia And More
November 10, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Poshmark, Inc. (NASDAQ: POSH) missed the quarter badly when others in that industry are doing quite well,...
Via
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Why Are Tandem Diabetes Shares Falling Premarket Today?
November 04, 2021
Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q3 sales of $179.6 million, +45% Y/Y, beating the consensus of $171.41 million. The Company posted EPS of $0.09, a...
Via
Benzinga
Tandem Diabetes Care, inc (TNDM) Q3 2021 Earnings Call Transcript
November 03, 2021
TNDM earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Tandem Diabetes Care: Q3 Earnings Insights
November 03, 2021
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Tandem Diabetes Care Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
September 30, 2021
A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance.
Via
Investor's Business Daily
Why Tandem Diabetes Care Stock Jumped Today
September 07, 2021
The stock is being added to the S&P MidCap 400 Index.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
45 Stocks Moving In Tuesday's Mid-Day Session
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...
Via
Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
This Simple Thing Sent These 3 Nasdaq Stocks Soaring Tuesday
September 07, 2021
All it takes is money -- big money.
Via
The Motley Fool
Topics
Stocks
Exposures
COVID-19
US Equities
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Match Stock, Tandem Diabetes Lead Big Movers Due To S&P Index Changes
September 07, 2021
Match will join the S&P 500 and Tandem Diabetes the S&P MidCap 400. UniQure enters the SmallCap 600.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
72 Biggest Movers From Yesterday
September 08, 2021
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market...
Via
Benzinga
5 Stocks Insiders Are Selling
August 19, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
Tandem Diabetes Care Stock Sees Improved Relative Strength
August 16, 2021
The Relative Strength (RS) Rating for Tandem Diabetes Care stock moved up into a higher percentile Monday, as it got a lift from 68 to 73.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.